After Cowen & Co. and J.P. Morgan gave Ultragenyx Pharmaceutical (NASDAQ: RARE) a Buy rating last month, the company received
Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Regeneron (REGN – Research Report) today and set a price
Citigroup analyst Prashant Rao maintained a Buy rating on Phillips 66 (PSX – Research Report) today and set a price
In a report released today, Matthew Harrison from Morgan Stanley maintained a Buy rating on Amgen (AMGN – Research Report),
Analysts have been eager to weigh in on the Financial sector with new ratings on BNY Mellon (BK – Research
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alexion Pharmaceuticals (ALXN – Research
In a report issued on January 14, Leland Gershell from Oppenheimer maintained a Buy rating on Veru (VERU – Research
